CTNI-57. RADIONUCLIDE THERAPY WITH 177LU-DOTATATE (LUTATHERA) IN ADULTS WITH ADVANCED INTRACRANIAL MENINGIOMA - INTERIM ANALYSIS RESULTS OF A SINGLE-ARM, OPEN-LABEL, MULTICENTER PHASE II STUDY
Sylvia C. Kurz(Center for Neuro-Oncology), Erik P. Sulman(NYU Langone Health), Elçin Zan(Cornell University), Marissa Barbaro(NYU Langone Health), David Zagzag(NYU Langone Health), John G. Golfinos(NYU Langone Health), David Kondziolka(New York University), Matija Snuderl, Christine Cordova(Cleveland Clinic), Joshua S. Silverman(NYU Langone Health), Andrea B. Troxel(Andover Eye Associates)
Cited by 2
Related Papers
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
|New England Journal of Medicine|2014|2.8k
Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19
|New England Journal of Medicine|2020|1.1k